Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients

    NEXT STORY
    Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
    PREV STORY
    Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

    LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a ...

    author_avatar
    NASDAQ Market News

    Mateon and Asili Research Alliance Enter Into Partnership for the Development of Artemisinin Against Covid-19

    author_avatar
    NASDAQ Market News